Fig. 4From: Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristicsClinical experience with DecisionDx-UM testing. a Proportions of tissue type received for testing. b Proportions of Class 1A, 1B, and 2 results in clinical setting from January 2010-May 2016. c Technical success of DecisionDx-UM testing and proportions of technical failures due to multi-gene failures, out-of-specification samples, and insufficient tumor densityBack to article page